Guardant Health
365 hedge funds and large institutions have $6.47B invested in Guardant Health in 2025 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 128 increasing their positions, 115 reducing their positions, and 44 closing their positions.
57% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 44
27% more capital invested
Capital invested by funds: $5.1B → $6.47B (+$1.37B)
11% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 115
7% more funds holding
Funds holding: 342 → 365 (+23)
3.34% more ownership
Funds ownership: 97% → 100.34% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
30% less call options, than puts
Call options by funds: $89.1M | Put options by funds: $126M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$72.6M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$63.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$50.7M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$45.5M |
| 5 |
RI
RTW Investments
New York
|
+$38.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
-$63.2M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$53.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$49M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$39.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$32.2M |
GH Hedge Fund Activity: Q2 2025 in Review
365 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q2 2025, worth a combined $6.47B — up 27% from $5.1B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new GH positions and 44 closed out — a net gain of 25 holders — while 128 added to existing stakes and 115 trimmed.
The largest buyer was Millennium Management, adding an estimated $72.6M. The largest seller was Cadian Capital Management, cutting an estimated $63.2M.
- 365 institutional investors held Guardant Health (GH) as of Q2 2025, up from 342 in Q1 2025.
- Funds reported $6.47B of Guardant Health stock for Q2 2025, up 27% quarter-over-quarter.
- 69 funds opened new Guardant Health positions in Q2 2025 and 44 closed out, a net change of +25 holders.
- The largest Guardant Health buyer in Q2 2025 was Millennium Management, an estimated $72.6M added.
- The largest Guardant Health seller in Q2 2025 was Cadian Capital Management, an estimated $63.2M sold.
Based on aggregated 13F filings for Q2 2025.